A Randomised, Double-blind, Double-dummy, Three-period Cross-over Trial to Compare Post Prandial Blood Glucose Control of BioChaperone Combo With Humalog Mix25 and With Simultaneous Injections of Humalog and Lantus in Subjects With Type 2 Diabetes
Phase of Trial: Phase I
Latest Information Update: 04 Jul 2017
At a glance
- Drugs Insulin glargine/insulin lispro (Primary) ; Insulin glargine; Insulin lispro; Insulin neutral protamine lispro/insulin lispro
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Sponsors Adocia
- 28 Jun 2017 Status changed from recruiting to completed.
- 06 Jun 2017 Primary endpoint (Delta AUC BG 0-2h (area under the blood glucose concentration-time curve)) has been met according to an Adocia media release.
- 06 Jun 2017 Results published in an Adocia media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History